These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 34153128

  • 1. Prognostic value of cardiopulmonary exercise test after heart transplantation.
    Iglesias D, Masson W, Barbagelata L, Rossi E, Mora M, Cornejo G, Lagoria J, Belziti C, Vulcano N, Marenchino R, Pizarro R, Ventura H.
    Clin Transplant; 2021 Aug; 35(8):e14387. PubMed ID: 34153128
    [Abstract] [Full Text] [Related]

  • 2. Sinus tachycardia is associated with impaired exercise tolerance following heart transplantation.
    Peled Y, Varnado S, Lowes BD, Zolty R, Lyden ER, Moulton MJ, Um JY, Raichlin E.
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28251691
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy.
    Sinagra G, Iorio A, Merlo M, Cannatà A, Stolfo D, Zambon E, Di Nora C, Paolillo S, Barbati G, Berton E, Carriere C, Magrì D, Cattadori G, Confalonieri M, Di Lenarda A, Agostoni P.
    Int J Cardiol; 2016 Nov 15; 223():596-603. PubMed ID: 27561166
    [Abstract] [Full Text] [Related]

  • 4. Oxygen Consumption at Anaerobic Threshold Predicts Cardiac Events After Heart Transplantation.
    Tsai HY, Tsai WJ, Kuo LY, Lin YS, Chen BY, Lin WH, Shen SL, Huang HY.
    Transplant Proc; 2018 Nov 15; 50(9):2742-2746. PubMed ID: 30401388
    [Abstract] [Full Text] [Related]

  • 5. Impaired Exercise Tolerance Early After Heart Transplantation Is Associated With Development of Cardiac Allograft Vasculopathy.
    Yu MD, Liebo MJ, Lundgren S, Salim AM, Joyce C, Zolty R, Moulton MJ, Um JY, Lowes BD, Raichlin E.
    Transplantation; 2020 Oct 15; 104(10):2196-2203. PubMed ID: 31929429
    [Abstract] [Full Text] [Related]

  • 6. Value of peak exercise oxygen consumption combined with B-type natriuretic peptide levels for optimal timing of cardiac transplantation.
    Kato TS, Collado E, Khawaja T, Kawano Y, Kim M, Farr M, Mancini DM, Schulze PC.
    Circ Heart Fail; 2013 Jan 15; 6(1):6-14. PubMed ID: 23204059
    [Abstract] [Full Text] [Related]

  • 7. Peak oxygen uptake and self-reported physical health are strong predictors of long-term survival after heart transplantation.
    Yardley M, Havik OE, Grov I, Relbo A, Gullestad L, Nytrøen K.
    Clin Transplant; 2016 Feb 15; 30(2):161-9. PubMed ID: 26589579
    [Abstract] [Full Text] [Related]

  • 8. Recovery kinetics of oxygen uptake after cardiopulmonary exercise test and prognosis in patients with left ventricular dysfunction.
    Queirós MC, Mendes DE, Ribeiro MA, Mendes M, Rebocho MJ, Seabra-Gomes R.
    Rev Port Cardiol; 2002 Apr 15; 21(4):383-98. PubMed ID: 12090125
    [Abstract] [Full Text] [Related]

  • 9. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure.
    Di Salvo TG, Mathier M, Semigran MJ, Dec GW.
    J Am Coll Cardiol; 1995 Apr 15; 25(5):1143-53. PubMed ID: 7897128
    [Abstract] [Full Text] [Related]

  • 10. Cardiopulmonary exercise testing in the evaluation of liver disease in adults who have had the Fontan operation.
    Agarwal A, Cunnington C, Sabanayagam A, Zier L, McCulloch CE, Harris IS, Foster E, Atkinson D, Bryan A, Jenkins P, Dua J, Parker MJ, Karunaratne D, Moore JA, Meadows J, Clarke B, Hoschtitzky JA, Mahadevan VS.
    Arch Cardiovasc Dis; 2018 Apr 15; 111(4):276-284. PubMed ID: 29198937
    [Abstract] [Full Text] [Related]

  • 11. The Influence of Sex Differences on Cardiopulmonary Exercise Metrics Following Heart Transplant.
    Uithoven KE, Smith JR, Medina-Inojosa JR, Squires RW, Van Iterson EH, Olson TP.
    Can J Cardiol; 2020 Jan 15; 36(1):54-59. PubMed ID: 31607508
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of a new cardiopulmonary exercise testing parameter in chronic heart failure: oxygen uptake efficiency at peak exercise - comparison with oxygen uptake efficiency slope.
    Toste A, Soares R, Feliciano J, Andreozzi V, Silva S, Abreu A, Ramos R, Santos N, Ferreira L, Ferreira RC.
    Rev Port Cardiol; 2011 Oct 15; 30(10):781-7. PubMed ID: 22118129
    [Abstract] [Full Text] [Related]

  • 13. Cardiopulmonary Exercise Testing Provides Additional Prognostic Information in Cystic Fibrosis.
    Hebestreit H, Hulzebos EHJ, Schneiderman JE, Karila C, Boas SR, Kriemler S, Dwyer T, Sahlberg M, Urquhart DS, Lands LC, Ratjen F, Takken T, Varanistkaya L, Rücker V, Hebestreit A, Usemann J, Radtke T, Prognostic Value of CPET in CF Study Group.
    Am J Respir Crit Care Med; 2019 Apr 15; 199(8):987-995. PubMed ID: 30321487
    [Abstract] [Full Text] [Related]

  • 14. Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction.
    Nadruz W, West E, Sengeløv M, Santos M, Groarke JD, Forman DE, Claggett B, Skali H, Shah AM.
    J Am Heart Assoc; 2017 Oct 31; 6(11):. PubMed ID: 29089342
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the Seattle heart failure model and cardiopulmonary exercise capacity for prediction of death in patients with chronic ischemic heart failure and intracoronary progenitor cell application.
    Honold J, DeRosa S, Spyridopoulos I, Fischer-Rasokat U, Seeger FH, Leistner D, Lotz S, Levy WC, Zeiher AM, Assmus B.
    Clin Cardiol; 2013 Mar 31; 36(3):153-9. PubMed ID: 23377956
    [Abstract] [Full Text] [Related]

  • 16. Prognostic Role of Cardiopulmonary Exercise Testing in Wild-Type Transthyretin Amyloid Cardiomyopathy Patients Treated With Tafamidis.
    Dalia T, Acharya P, Chan WC, Sauer AJ, Weidling R, Fritzlen J, Goyal A, Miller D, Knipper E, Porter CB, Shah Z.
    J Card Fail; 2021 Nov 31; 27(11):1285-1289. PubMed ID: 34280522
    [Abstract] [Full Text] [Related]

  • 17. Cardiopulmonary exercise testing in chronic heart failure patients treated with beta-blockers: Still a valid prognostic tool.
    Corrà U, Giordano A, Piepoli M.
    Int J Cardiol; 2020 Oct 15; 317():128-132. PubMed ID: 32611497
    [Abstract] [Full Text] [Related]

  • 18. Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease.
    Bernal W, Martin-Mateos R, Lipcsey M, Tallis C, Woodsford K, McPhail MJ, Willars C, Auzinger G, Sizer E, Heneghan M, Cottam S, Heaton N, Wendon J.
    Liver Transpl; 2014 Jan 15; 20(1):54-62. PubMed ID: 24136710
    [Abstract] [Full Text] [Related]

  • 19. Effect of diltiazem on exercise capacity after heart transplantation.
    Varnado S, Peled-Potashnik Y, Huntsberry A, Lowes BD, Zolty R, Burdorf A, Lyden ER, Moulton MJ, Um JY, Raichlin E.
    Clin Transplant; 2017 Aug 15; 31(8):. PubMed ID: 28477381
    [Abstract] [Full Text] [Related]

  • 20. The value of cardiopulmonary exercise testing and stress echocardiography in the prediction of all-cause mortality in adults with end-stage renal disease.
    O'Driscoll JM, Edwards JJ, Greenhough E, Smith E, May M, Gupta S, Marciniak A, Sharma R.
    Eur J Sport Sci; 2023 Aug 15; 23(8):1800-1809. PubMed ID: 36815759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.